The latest on Google’s battle plan against death: analyzing the genetics of aging

google sign
Image via CNN. Credit: Tony Avelar/Bloomberg/Getty

Google (GOOG) last month made waves in the biotech world by announcing the formation of Calico, a “new company that will focus on health and well-being, in particular the challenge of aging and associated diseases.” 

Beyond that, nada. So I did a bit of digging while in Silicon Valley last week, and have learned much more.

Now that the entire genome had been coded, Bill Maris, the Google Ventures managing partner, wondered if it was possible to actually study the genetic causes of aging and then create drugs to address them. For example, what if you examined the genomes of thousands of healthy 90 year-olds from all parts of the world? What genetic similarities do they have?

Read the full, original story here: New details on Google’s anti-aging startup

Additional Resources:

 

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}
screenshot at  pm

Are pesticide residues on food something to worry about?

In 1962, Rachel Carson’s Silent Spring drew attention to pesticides and their possible dangers to humans, birds, mammals and the ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.